It is a pharma private limited company based in Tiruvannamalai, Tamil Nadu, India, established in 2019.
2019 | Tiruvannamalai, Tamil Nadu, India | ActiveInnocure Pharma Private Limited, a active private limited company, was established on 05 September 2019 in Tiruvannamalai, Tamil Nadu, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U85300TN2019PTC131466. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹6.50 Cr and a paid-up capital of ₹6.13 Cr.
Its leadership includes Unjanai Kaliannan Chitrarasan (Director), Marimuthu Valarmathi (Director), Chinnusamy Balasubramanian (Director). Past directors included Venkatachalam Natarajan. It holds ₹9.00 Cr open charges and no settled loans. Its latest AGM occurred on 25 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.C15, Sipcot Industrial Complex, Cheyyar Phase Ii, Mathur Village, Vembak, Kam Taluk, Tiruvannamalai, Tamil Nadu, 631701.
U85300TN2019PTC131466
131466
05 September 2019
₹6.50 Cr
₹6.13 Cr
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Innocure Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Unjanai Kaliannan Chitrarasan | Director | 27 Mar 2025 | Current |
| Marimuthu Valarmathi | Director | 05 Sep 2019 | Current |
| Chinnusamy Balasubramanian | Director | 05 Sep 2019 | Current |
| Kuppusamy Palanivelu | Director | 05 Sep 2019 | Current |
| Venkatachalam Natarajan | Managing Director | 05 Sep 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 22 May 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Innocure Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 55.64% decrease in profit. The company's net worth Soared by an impressive increase of 154.37%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Innocure Pharma had a promoter holding of 80.03% and a public holding of 19.97%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹90,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Jul 2022 | Others | ₹9.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Innocure Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Innocure Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Innocure Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Unjanai Kaliannan Chitrarasan was appointed as a Director was appointed as a Director on 27 Mar 2025 & has been associated with this company since 8 months 6 days . was documented.
The activity Innocure Pharma Private Limited last Annual general meeting of members was held on 25 Sep 2024 as per latest MCA records. was completed.
Progress on Innocure Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was documented.
Progress on A charge with Others amounted to Rs. 9.00 Cr with Charge ID 100596618 was registered on 22 Jul 2022. was documented.
Progress on Marimuthu Valarmathi was appointed as a Director was appointed as a Director on 05 Sep 2019 & has been associated with this company since 6 years 2 months . was documented.
Progress on Chinnusamy Balasubramanian was appointed as a Director was appointed as a Director on 05 Sep 2019 & has been associated with this company since 6 years 2 months . was documented.
The CIN of Innocure Pharma Private Limited is U85300TN2019PTC131466.
Innocure Pharma Private Limited is headquartered at Plot No.C15, Sipcot Industrial Complex, Cheyyar Phase Ii, Mathur Village, Vembak, Kam Taluk, Tiruvannamalai, Tamil Nadu, 631701.
Innocure Pharma Private Limited was incorporated on 05 September 2019.
The current directors of Innocure Pharma Private Limited are
The primary industry of Innocure Pharma Private Limited is Pharma.
Innocure Pharma Private Limited is unlisted.
The authorized capital of Innocure Pharma Private Limited is ₹6.50 Cr, and the paid-up capital is ₹6.13 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX